Each month, this advisory presents the best stock for the current market conditions. You will build a diversified portfolio of the best growth, momentum, value, international and dividend stocks for a very affordable price.
Tim Lutts is not only the Chief Analyst of Cabot Stock of the Month; he is also Cabot’s Chief Investment Strategist. This puts Tim in a unique position to select the most attractive stock from five Cabot advisories.
Cabot Stock of the Month recommends one stock each month from five other Cabot advisories, including value stocks, growth stocks, momentum stocks, dividend stocks and international stocks, depending on what appears to be the most promising stock for the current market conditions. The advisory does not present a model portfolio—i.e., there's no cash position, weightings, etc.; however, all recommendations are followed up weekly with buy, hold and eventually sell ratings. The performance shown is the average gain of Cabot Stock of the Month's current holdings, as of 10/30/15.
105% in Stryker
78% in Melco Crown Entertainment
72% in Express Scripts
69% in Salix Pharmaceuticals
Try Cabot Stock of the Month risk-free for 12 months.
What our Customers say about Cabot Stock of the Month
An easy way to invest without any worry.
D. Aston, Florence, Alabama
This is exactly the kind of information I need. Please keep it up.
T. Picking, Pueblo, Colorado
It is your qualities of truthfulness, honesty and candor that have drawn me to the Cabot family of letters and to date, I am very pleased. The yo-yo effect of the market has not phased me. Reading your letters are like a prayer to me...they calm me.
A. Khorsandian, Daytona Beach, Florida
Are you ready to get started with your risk-free trial subscription?